GlassScriptPhysician profile
Nathaniel C Lawson
NPI 1598039158
$195,317.38
in general payments reported to CMS, 2019-2025
21 companies · $16K in 2025
The $16K reported for 2025 was more than what 99% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $25K · 2021: $26K · 2022: $37K · 2023: $44K · 2024: $25K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $39K · Honoraria: $21K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,140 · Travel and Lodging: $7,549 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,750 · Food and Beverage: $2,661 · Gift: $1,219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $38,975.00 |
| Honoraria | $20,750.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,140.00 |
| Travel and Lodging | $7,548.96 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,750.00 |
| Food and Beverage | $2,660.65 |
| Gift | $1,219.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulpdent Corporation | $47,500.00 | 2022-2025 | |
| Dentsply LLC | $24,412.34 | 2019-2023 | |
| Kuraray America INC. | $21,240.67 | 2019-2025 | |
| Dentsply Sirona INC | $21,026.95 | 2019-2023 | |
| 3m Company | $16,915.92 | 2019-2023 | Clarity Aligners, Scotchbond Universal Plus, 3m Espe Filtek Supreme Ultra Universal Restorative |
| Ivoclar Vivadent, INC. | $15,628.69 | 2019-2023 | |
| Clinician'S Choice Dental Products INC. | $14,845.64 | 2021-2024 | |
| Dmg America LLC | $12,467.30 | 2019-2023 | Icon |
| Bisco, INC. | $9,605.09 | 2020-2025 | |
| Solventum Corporation | $4,758.06 | 2024-2025 | 3m Filtek, Clarity Aligners, Filtek |
| Garrison Dental Solutions | $2,219.00 | 2025 | Quad Tall Ring: 2 Per Package, Quad Sectional Matrix System Deluxe Kit, Band Wedge Instrument |
| Peter Brasseler Holdings, LLC | $1,275.00 | 2021 | |
| Gc America INC. | $1,270.81 | 2021-2023 | G-Aenial |
| Den-Mat Holdings, LLC | $1,250.00 | 2025 | |
| Doxa Dental, INC. | $500.00 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tokuyama Dental America INC. | $250.00 | 2022 | |
| Kerr Corporation | $61.17 | 2020-2023 | Harmonize, Maxcem Elite |
| Zest Holdings, LLC | $40.03 | 2020 | |
| Nobel Biocare USA | $39.07 | 2023 | Nobelactive |
| Kulzer, LLC | $11.64 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Lawson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.